DEF 14AThe Ballot
Outlook Therapeutics, Inc. files DEF 14A
Filed Sep 29, 2017 · 8y ago · Accession 0001571049-17-008053
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Outlook Therapeutics, Inc.
- Ticker
- OTLK
- CIK
- 1649989
- Form type
- DEF 14A
- Filing date
- Sep 29, 2017
- Report date
- Oct 26, 2017
- Document
- t1702657-def14a.htm
- Size
- 1.3 MB